296 related articles for article (PubMed ID: 12649300)
1. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
Pauwels PJ; Rauly I; Wurch T
J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
[TBL] [Abstract][Full Text] [Related]
2. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
[TBL] [Abstract][Full Text] [Related]
3. Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
Pauwels PJ; Rauly I; Wurch T; Colpaert FC
Neuropharmacology; 2002 May; 42(6):855-63. PubMed ID: 12015212
[TBL] [Abstract][Full Text] [Related]
4. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
Pauwels PJ; Tardif S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
[TBL] [Abstract][Full Text] [Related]
5. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
Brink CB; Wade SM; Neubig RR
J Pharmacol Exp Ther; 2000 Aug; 294(2):539-47. PubMed ID: 10900230
[TBL] [Abstract][Full Text] [Related]
6. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
Tian WN; Duzic E; Lanier SM; Deth RC
Mol Pharmacol; 1994 Mar; 45(3):524-31. PubMed ID: 8145737
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
Pauwels PJ; Tardif S; Colpaert FC; Wurch T
Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
[TBL] [Abstract][Full Text] [Related]
8. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
9. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Dec; 131(7):1385-90. PubMed ID: 11090111
[TBL] [Abstract][Full Text] [Related]
10. alpha(2A)-adrenoceptor: G(alphai1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway.
Rauly I; Ailhaud M; Wurch T; Pauwels PJ
Biochem Pharmacol; 2000 Jun; 59(12):1531-8. PubMed ID: 10799649
[TBL] [Abstract][Full Text] [Related]
11. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein.
Wurch T; Okuda J; Pauwels PJ
Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427
[TBL] [Abstract][Full Text] [Related]
13. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
Wurch T; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
[TBL] [Abstract][Full Text] [Related]
14. Protean agonism at alpha2A-adrenoceptors.
Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
[TBL] [Abstract][Full Text] [Related]
15. Alpha(2)-adrenoceptor-stimulated GTP gamma S binding in rat brain: an autoradiographic study.
Happe HK; Bylund DB; Murrin LC
Eur J Pharmacol; 2000 Jun; 399(1):17-27. PubMed ID: 10876018
[TBL] [Abstract][Full Text] [Related]
16. Receptor reserve analysis of the human alpha(2C)-adrenoceptor using.
Umland SP; Wan Y; Shah H; Billah M; Egan RW; Hey JA
Eur J Pharmacol; 2001 Jan; 411(3):211-21. PubMed ID: 11164378
[TBL] [Abstract][Full Text] [Related]
17. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding.
Jasper JR; Lesnick JD; Chang LK; Yamanishi SS; Chang TK; Hsu SA; Daunt DA; Bonhaus DW; Eglen RM
Biochem Pharmacol; 1998 Apr; 55(7):1035-43. PubMed ID: 9605427
[TBL] [Abstract][Full Text] [Related]
18. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of alpha2D-adrenergic receptor-mediated [35S]GTPgammaS binding in rat cerebral cortical membranes.
Odagaki Y; Toyoshima R
Pharmacol Res; 2008 Jun; 57(6):435-44. PubMed ID: 18515144
[TBL] [Abstract][Full Text] [Related]
20. Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
Trendelenburg AU; Wahl CA; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):245-9. PubMed ID: 8692278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
